Institute of Cancer Research (ICR)

Innovative cancer drugs are taking longer to get to patients due to delays in clinical trials and regulatory red tape, new data shows. Read more


A combination of drugs has offered promising results in an early clinical trial, where it has shrunk tumours in ovarian and lung cancer patients and prevented tumour growth for nearly six months. Read more


London-based scientists have found a new blood test that may be able to quickly predict if a female patient is responding to the breast cancer drug, palbociclib, earlier that is possible with currently available tests. Read more


ICR PhD student and Royal Marsden Hospital haematology registrar Dr. Charlotte Pawlyn has been awarded a Women in Cancer Research Scholar Award at the AACR annual meeting in Philadelphia. Read more